Оцінка ефективності лікування хворих на астма/хозл перехрест з та без ожиріння з урахуванням поліморфного варіанта c646g гена nr3c1 (rs41423247)

HIGHLIGHTS

• who: Dima from the (UNIVERSITY) have published the Article: u041eu0426u0406u041du041au0410 u0415u0424u0415u041au0422u0418u0412u041du041eu0421u0422u0406 u041bu0406u041au0423u0412u0410u041du041du042f u0425u0412u041eu0420u0418u0425 u041du0410 u0410u0421u0422u041cu0410/u0425u041eu0417u041b u041fu0415u0420u0415u0425u0420u0415u0421u0422 u0417 u0422u0410 u0411u0415u0417 u041eu0416u0418u0420u0406u041du041du042f u0417 u0423u0420u0410u0425u0423u0412u0410u041du041du042fu041c u041fu041eu041bu0406u041cu041eu0420u0424u041du041eu0413u041e u0412u0410u0420u0406u0410u041du0422u0410 C646G u0413u0415u041du0410 NR3C1 (RS41423247), in the Journal: (JOURNAL)
• what: This study evaluates the possibility of using the C646G polymorphic variant of the NR3C1 gene (rs41423247) for the personalized administration of combination therapy with inhaled glucocorticosteroids (iGCs) and long-acting u03b22-agonists in patients with asthma/COPD overlap (ACO) with and without obesity.

SUMMARY

The Aim. The CAT test, the asthma control questionnaire (Asthma Control Questionnaire-5 . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.